Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bode

Showing results (271-280 of 756) with videos related to

Pageof 76
Sort By:
Journal of Chemical Information and Modeling|September 30, 2011
Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structuresYan Li, Dong Joon Kim, Weiya Ma, et al.
Nephron. Clinical Practice|January 31, 2008
Response of asymmetric dimethylarginine to hemodialysis-associated hypotension in end-stage renal disease patientsBotond Csiky, Endre Sulyok, Orsolya Lakatos, et al.
International Journal of Biological Sciences|November 24, 2016
Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisHongde Li, Sufang Liu, Jianmin Hu, et al.
Cancer Research|May 14, 2009
A regulatory mechanism for RSK2 NH(2)-terminal kinase activityYong-Yeon Cho, Ke Yao, Angelo Pugliese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2006
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysisJan T Kielstein, Shelley R Salpeter, Stefanie M Bode-Boeger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2010
Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patientsInes Reiche, Sabine Westphal, Jens Martens-Lobenhoffer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2019
Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validationMarco Pirisinu, Pilar Blasco, Xueli Tian, et al.
European Journal of Pharmacology|July 21, 2024
The role of novel protein acylations in cancerDan Cao, Wenxuan Sun, Xinyi Li, et al.
European Journal of Clinical Investigation|April 26, 2003
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failureJ T Kielstein, S M Bode-Böger, G Klein, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial agingFortunato Scalera, Jens Martens-Lobenhoffer, Alicja Bukowska, et al.
Pageof 76

Showing results (271-280 of 756) with videos related to

Sort By:
Pageof 76
Journal of Chemical Information and Modeling|September 30, 2011
Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structuresYan Li, Dong Joon Kim, Weiya Ma, et al.
Nephron. Clinical Practice|January 31, 2008
Response of asymmetric dimethylarginine to hemodialysis-associated hypotension in end-stage renal disease patientsBotond Csiky, Endre Sulyok, Orsolya Lakatos, et al.
International Journal of Biological Sciences|November 24, 2016
Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisHongde Li, Sufang Liu, Jianmin Hu, et al.
Cancer Research|May 14, 2009
A regulatory mechanism for RSK2 NH(2)-terminal kinase activityYong-Yeon Cho, Ke Yao, Angelo Pugliese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2006
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysisJan T Kielstein, Shelley R Salpeter, Stefanie M Bode-Boeger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2010
Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patientsInes Reiche, Sabine Westphal, Jens Martens-Lobenhoffer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2019
Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validationMarco Pirisinu, Pilar Blasco, Xueli Tian, et al.
European Journal of Pharmacology|July 21, 2024
The role of novel protein acylations in cancerDan Cao, Wenxuan Sun, Xinyi Li, et al.
European Journal of Clinical Investigation|April 26, 2003
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failureJ T Kielstein, S M Bode-Böger, G Klein, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial agingFortunato Scalera, Jens Martens-Lobenhoffer, Alicja Bukowska, et al.
Pageof 76